Value of IUS in Predicting Vedolizumab Efficacy and Assessing Transmural Healing in Early Crohn's Disease: A Multicenter, Prospective Study

Clinical trial NCT07093294 · RECRUITING

Trial details

NCT number: NCT07093294
Sponsor: The Third Xiangya Hospital of Central South University
Status: RECRUITING
Study type: OBSERVATIONAL

Crohn Disease (CD)Vedolizumab Intestinal Ultrasound Predictor

Start date: 2025-06-01
Primary completion: 2027-06-30
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.